CELLDEX Trademark

Trademark Overview

On Thursday, April 13, 2023, a trademark application was filed for CELLDEX with the United States Patent and Trademark Office. The USPTO has given the CELLDEX trademark a serial number of 97887331. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, June 12, 2025. This trademark is owned by CELLDEX. The CELLDEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer
celldex

General Information

Serial Number97887331
Word MarkCELLDEX
Filing DateThursday, April 13, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, June 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCELLDEX
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827
Party NameCELLDEX
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827

Trademark Events

Event DateEvent Description
Tuesday, April 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023NEW APPLICATION ENTERED
Tuesday, April 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 5, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, May 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 26, 2023ASSIGNED TO LIE
Tuesday, September 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 26, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, January 9, 2024ASSIGNED TO EXAMINER
Tuesday, January 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 8, 2024SOU EXTENSION 1 FILED
Monday, November 11, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 6, 2025NOTICE OF REVIVAL - E-MAILED
Tuesday, May 6, 2025TEAS PETITION TO REVIVE RECEIVED
Monday, November 11, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, April 8, 2025SOU EXTENSION 2 FILED
Tuesday, May 6, 2025PETITION TO REVIVE-GRANTED
Tuesday, May 6, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, May 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 9, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 12, 2025SOU EXTENSION 1 GRANTED
Thursday, June 12, 2025SOU EXTENSION 2 GRANTED
Friday, June 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

celldex treatment antibodies human therapeutic cancer inflammatory preparations inflammation pharmaceutical diseases